SCHEMBL18954712

SCHEMBL18954712

CCOC(=O)CCN1C(=O)C(=O)c2cc(F)c(Cl)cc21

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.47
▸ KAT2B Q92831 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ S1PR1 P21453 1/20 0.41
▸ S1PR3 Q99500 1/20 0.41
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ ATM Q13315 1/20 0.39
▸ TNF P01375 1/20 0.39
▸ PPOX P50336 1/20 0.39
▸ GSK3A P49840 1/20 0.37
▸ GSK3B P49841 1/20 0.37
▸ PARK7 Q99497 2/20 0.36
▸ PIN1 Q13526 1/20 0.36
▸ PIN4 Q9Y237 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18954538 0.93 ALDH1A1 (0.46) ALDH1A1KAT2BLMNAMAPTHTT
SCHEMBL18954631 0.78 PARK7 (0.58) ALDH1A1LMNAMAPTHSD17B10GSK3A
SCHEMBL28527361 0.76 CES1 (0.43) ALDH1A1MAPTMEN1KMT2APARK7
SCHEMBL18955128 0.76 ALDH1A1 (0.58) ALDH1A1LMNAMAPTHTTHSD17B10
SCHEMBL18954460 0.76 ALDH1A1 (0.47) ALDH1A1KAT2BLMNAMAPTHTT
SCHEMBL18954706 0.75 ALDH1A1 (0.43) ALDH1A1MAPTHTTHSD17B10MEN1
SCHEMBL18954505 0.75 ALDH1A1 (0.61) ALDH1A1LMNAMAPTHTTHSD17B10
SCHEMBL18954742 0.75 PPOX (0.39) ALDH1A1LMNAMAPTHTTHSD17B10
SCHEMBL18974747 0.75 CES1 (0.59) ALDH1A1MAPTHTTHSD17B10KMT2A
SCHEMBL18954583 0.74 ALDH1A1 (0.47) ALDH1A1MAPTHTTHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 — — WO disclosed
Send feedback